Eva Wex
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inhalation and Respiratory Drug Delivery
- Immunology top 10%
- Galectins and Cancer Biology
- Mast cells and histamine
Papers in
- Genetics 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
-
- Asthma and respiratory diseases 5
- Co-authors
- Lutz Wollin (4 shared papers)Alexander Pautsch (1 shared paper)Gisela Schnapp (1 shared paper)Martin R.J. Kolb (1 shared paper)Susanne Stowasser (1 shared paper)Katrin Hostettler (1 shared paper)Florian Gantner (3 shared papers)Andreas Schnapp (2 shared papers)
- Journals
- British Journal of Pharmacology (2 papers)PLoS ONE (2 papers)European Journal of Immunology (1 paper)Nature Medicine (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Eva Wex
11 papers receiving 1.4k citations
Eva Wex's Hit Papers
Peers
Comparison fields: 5 of 96
- Pulmonary and Respiratory Medicine 660
- Immunology 318
- Radiology, Nuclear Medicine and Imaging 217
- Immunology and Allergy 50
- Rheumatology 110
Countries citing papers authored by Eva Wex
This map shows the geographic impact of Eva Wex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Wex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Wex more than expected).
Fields of papers citing papers by Eva Wex
This network shows the impact of papers produced by Eva Wex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Wex. The network helps show where Eva Wex may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Wex, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis Hit paper breakdown → | 2015 | 786 |
| 2 | 2012 | 387 | |
| 3 | 2013 | 83 | |
| 4 | 2010 | 32 | |
| 5 | 2011 | 28 | |
| 6 | 2015 | 22 | |
| 7 | 2016 | 22 | |
| 8 | 2017 | 18 | |
| 9 | 2015 | 16 | |
| 10 | 2014 | 14 | |
| 11 | 2015 | 10 |
About Eva Wex
Eva Wex is a scholar working on Genetics, Physiology, Immunology, Sensory Systems and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 1.4k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (5 papers), Mast cells and histamine (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Respiratory and Cough-Related Research (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Ion Channels and Receptors (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Complement system in diseases (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (660 citations), Immunology (318 citations), Radiology, Nuclear Medicine and Imaging (217 citations), Immunology and Allergy (50 citations) and Rheumatology (110 citations). Eva Wex has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Lutz Wollin, Alexander Pautsch, Gisela Schnapp, Martin R.J. Kolb, Susanne Stowasser, Katrin Hostettler, Florian Gantner, Andreas Schnapp, Michael P. Sanderson and Daniel Seeliger. Their work appears in journals such as British Journal of Pharmacology, PLoS ONE, European Journal of Immunology, Nature Medicine and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.